Document Detail

Effectiveness of infliximab in treating selected patients with sarcoidosis.
MedLine Citation:
PMID:  16935484     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To assess the effectiveness of infliximab (Remicade) in the treatment of patients with sarcoidosis who either do not respond to corticosteroids and other conventional drugs or develop unacceptable side effects to these drugs. DESIGN: A clinical, non-randomized, off-label study. SETTING: Sarcoidosis clinic at a university teaching hospital. PATIENTS: Twelve biopsy-proven sarcoidosis patients, nine women and three men ranging from 45 to 70 years of age with chronic multisystem sarcoidosis refractory to corticosteroids or alternative treatment. INTERVENTION: Infliximab was infused at a dedicated ambulatory infusion center. The initial dose was 3mg/kg body weight and subsequent doses were given at weeks 2, 4, 6, 10, and 14. All patients received at least six infusions. RESULTS: All 12 patients improved significantly. One patient had a mild allergic drug reaction that responded to antihistamine. One patient, after 3 months of stopping infliximab treatment, died of a ruptured blood vessel in the abdomen. At autopsy a plasma cell dyscrasia was found. CONCLUSION: Infliximab is safe and effective in treating those patients with multisystem sarcoidosis who are either refractory or develop side effects to a standard regimen of corticosteroids and immunosuppressive agents.
Samer Saleh; Shahriar Ghodsian; Violeta Yakimova; John Henderson; Om P Sharma
Related Documents :
20133204 - Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic infla...
7062504 - Chronic, recurrent small-vessel cutaneous vasculitis. clinical experience in 13 patients.
16258654 - Guillain-barré syndrome in the elderly: clinical, electrophysiological, therapeutic an...
19825284 - Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with ...
21547704 - Detection and management of hypothyroidism following thyroid lobectomy: evaluation of a...
21652164 - Thoracic sympathectomy for digital ischemia: a summary of evidence.
Publication Detail:
Type:  Case Reports; Clinical Trial; Journal Article     Date:  2006-08-28
Journal Detail:
Title:  Respiratory medicine     Volume:  100     ISSN:  0954-6111     ISO Abbreviation:  Respir Med     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-10     Completed Date:  2007-01-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  2053-9     Citation Subset:  IM    
Department of Medicine, Pulmonary & Critical Care Division, University of Southern California, 1200N, State St., GNH 11900, Los Angeles, CA 90033, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Inflammatory Agents / adverse effects,  therapeutic use*
Antibodies, Monoclonal / adverse effects,  therapeutic use*
Chronic Disease
Middle Aged
Sarcoidosis / drug therapy*,  pathology
Treatment Outcome
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Antibodies, Monoclonal; 0/infliximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implicat...
Next Document:  Design of highly efficient receptor sites by combination of cyclodextrin units and molecular cavity ...